Apollo Hospitals Share Price Rises 6%; Sees 42% PAT Jump in Q1 FY26 Results

Apollo Hospitals announces Q1FY26 results. The company reported consolidated revenues of ₹5,842 crore in Q1FY26, a 15% YoY increase compared to ₹5,086 crore in Q1FY25.

Key contributors included Healthcare Services (HCS) with ₹2,935 crore (11% YoY growth), AHLL at ₹435 crore (19% YoY growth), and Apollo HealthCo at ₹2,472 crore (19% YoY growth). The Gross Merchandise Value (GMV) of Apollo 24/7 stood at ₹682 crore.

EBITDA Performance

The company’s consolidated EBITDA rose 26% YoY to ₹852 crore, compared to ₹675 crore in Q1FY25.

This figure factors in Apollo 24/7 costs of ₹121 crore during the quarter, including ₹24 crore in non-cash ESOP charges, down from ₹150 crore in the same quarter last year. Segment-wise, HCS EBITDA stood at ₹718 crore (15% YoY growth), AHLL at ₹40 crore (31% YoY growth), and Apollo HealthCo at ₹94 crore.

Profit After Tax (PAT)

Apollo Hospitals posted a 42% YoY rise in consolidated PAT to ₹433 crore, compared to ₹305 crore in Q1FY25.

The Healthcare Services segment delivered ₹384 crore in PAT (17% YoY growth), while Apollo HealthCo contributed ₹57 crore. AHLL recorded a PAT loss of ₹8 crore. The company’s diluted EPS for Q1FY26 stood at ₹30.10 per share (not annualised).

Dr. Prathap C Reddy, Chairman, Apollo Hospitals Enterprise Ltd, said, “Looking ahead, we anticipate continued double digit revenue growth for FY26, underpinned by new hospital openings in Patna and Jaipur slated for Q3, further digital innovation, and deepening partnerships with state governments to bolster community-based health initiatives. I remain confident that Apollo will set new benchmarks in clinical excellence, patient experience, and sustainable growth-true to our founding mission of enabling healthier, happier lives for all.”

Apollo Hospitals Share Price Performance

On August 13, 2025, Apollo Hospitals share price (NSE: APOLLOHOSP) opened at ₹7,403.00, up from its previous close of ₹7,236.50. At 9:55 AM, the share price of Apollo Hospitals was trading at ₹7,684.00, up by 6.18% on the NSE.

Also Read: Apollo Hospitals’ Board Approves Listing of Pharmacy & Digital Health Unit!

Conclusion

Apollo Hospitals delivered a strong performance in Q1FY26, driven by revenue growth across segments, disciplined cost management, and improved profitability. With continued momentum in healthcare services, diagnostics, and digital health, the company is well-positioned for sustained growth in the upcoming quarters.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.